Elevance Health stock

ELV · NYSE · USD

Compare Elevance Health
$433.93Change from previous close: −2.77%Absolute change: −$12.35

Close · November 17, 2026

Price history

+32.24% over the period

1 year: from $330.91 (November 17, 2025) to $437.61 (November 17, 2026), +32.24%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 17, 2026$437.61
October 30, 2026$420.07
September 30, 2026$388.82
August 31, 2026$392.54
July 31, 2026$375.84
June 30, 2026$386.73
May 29, 2026$393.19
April 30, 2026$376.42
March 31, 2026$292.75
February 27, 2026$320.00
January 30, 2026$345.74
December 31, 2025$350.55
November 28, 2025$338.26
November 17, 2025$330.91

At a glance

TickerLandia's take on Elevance Health

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$274.84
52-wk high$450.69

−3.72% from the 52-week high

Analysts · 22 analysts

Average target$482.38+11.17% vs. price

Buy 15 · Hold 7 · Sell 0 · Buy

TickerLandia Fingerprint: Elevance Health

Compared with similar companies: strong momentum, low price, and high earnings stability.

Financials and price compared with 44 companies in related industries (health_services), worldwide. Momentum and risk compared with 883 North American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Elevance Health is priced as in the past and in line with similar companies

On the latest fiscal year's earnings (2025), Elevance Health's P/E today is 17.4, in line with the median of its last 10 fiscal years (17.1; between 13.9 and 20.7 from 2016 to 2025). Elevance Health's P/E (trailing 12 months): 18.9, in line with the median of a group of 7 similar companies (18.9).

P/E compared with its history

Compared with 7 similar companies

Elevance Health's metrics compared with similar companies
MetricElevance HealthPosition in the groupBand
P/E (trailing 12 months)18.9Middle
Forward P/E14.7Middle
Operating margin4.0%Middle
ROE11.5%Middle
Debt/equity0.69Low

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Elevance Health. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$51.43B

Latest quarter · Q3 2026

Net income

$1.37B

Latest quarter · Q3 2026

Quarterly net margin

2.7%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
$96.04B
P/E
18.9
EPS
$23.55
Volume
334.11K
Daily trading
€548.8M
Dividend yield
1.58%

How Elevance Health is changing

All results
  • Revenue grew 10.3% a year on average over the last 5 years

  • Operating margin fell from 5.4% to 3.6%

  • Free cash flow equal to 82% of net income

Returns

Elevance Health returns with dividends

$1,000 invested in Elevance Health 5 years ago, on November 17, 2021, would be worth $1,096 today with dividends reinvested: +9.57% in total, +1.85% per year. On price alone it would be $1,018 (+1.85%).

PeriodElevance HealthS&P 500$1,000 becomes
1 month+1.72%−3.17%$1,017
6 months+10.50%+0.11%$1,105
Year to date+24.84%+8.34%$1,248
1 year+34.86%+11.15%$1,349
3 years−0.60%+64.30%$994
5 years+9.57%+58.18%$1,096
10 years+264.21%+239.10%$3,642

Over the last 6 months it has done better than 39% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. S&P 500: price only. Calculate your investment

The chart in detail

Elevance Health: technical analysis

Elevance Health is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 22.8% below its all-time closing high ($562.29, September 3, 2024).

Trend
Upward
RSI (14 sessions)
55
Between 30 and 70
vs 200-session average
+15.26%

Support and resistance

Price areas where Elevance Health has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$449.62+3.61%2 touches, last on November 5, 2026
  2. Last price$433.93
  3. Support$427.08−1.58%2 touches, last on September 14, 2026
  4. Support$407.48−6.10%4 touches, last on November 2, 2026
  5. Support$391.10−9.87%2 touches, last on September 9, 2026

Volatility and risk

Over the last year it has moved little with the S&P 500.

Beta (1 year) vs S&P 500
0.27
Volatility (60 sessions, annualised)
27.5%
Largest fall in the last year
−26.49%

Close of November 17, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Elevance Health: seasonality

Average monthly price change over 25 years

+1.5%Jan−0.4%Feb+2.1%Mar+4.0%Apr+2.4%May−0.6%Jun−1.5%Jul+0.7%Aug−1.1%Sep+1.0%Oct+4.9%Nov+2.7%Dec

Over the last 25 years, the strongest month for Elevance Health has been November: +4.92% on average, positive in 18 years out of 25. The weakest has been July: −1.47% on average, positive in 13 years out of 25.

Show chart data
MonthAverageMedianPositive years
January+1.46%−0.39%12 of 25
February−0.38%+0.30%14 of 25
March+2.12%+4.06%18 of 25
April+3.97%+1.94%17 of 25
May+2.44%+3.09%18 of 25
June−0.56%−0.62%12 of 25
July−1.47%+0.58%13 of 25
August+0.73%+0.65%14 of 25
September−1.08%−0.95%9 of 25
October+1.00%+0.39%13 of 25
November+4.92%+5.26%18 of 25
December+2.67%+3.63%16 of 25

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Elevance Health and its competitors

Elevance Health operates across the United States, where it serves individuals, employer groups and government program members, including Medicare, Medicaid and FEP enrollees. Its health plans and related services range from risk-based and fee-based coverage to dental, vision and supplemental insurance, offered under the Anthem Blue Cross and Blue Shield, Wellpoint and Carelon brands. Its CarelonRx unit runs pharmacy services, including home delivery and specialty pharmacies, infusion services and claims adjudication, while other units provide behavioral health, palliative care and virtual care.

Headquarters
Indianapolis, United States
Employees
96,129
Founded
1944
Chief executive
Gail Boudreaux
Elevance Health and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Elevance HealthELV$96.04B4.0%18.9+10.50%
CVS HealthCVS$113.35B3.1%10.4−10.51%
Cigna GroupCI$77.95B3.9%12.2+3.08%
HumanaHUM$50.12B2.3%39.0+45.30%
CenteneCNC$33.52B1.9%22.8+24.51%
UnitedHealth GroupUNH$369.18B5.9%23.5−1.06%

Same industry or related industries, similar size. Compare Elevance Health with its competitors · Full profile